First Time Loading...

Novocure Ltd
NASDAQ:NVCR

Watchlist Manager
Novocure Ltd Logo
Novocure Ltd
NASDAQ:NVCR
Watchlist
Price: 14.78 USD 4.16% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

NVCR Price Targets Summary
Novocure Ltd

Wall Street analysts forecast NVCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVCR is 27.88 USD with a low forecast of 15.15 USD and a high forecast of 44.1 USD.

Lowest
Price Target
15.15 USD
3% Upside
Average
Price Target
27.88 USD
89% Upside
Highest
Price Target
44.1 USD
198% Upside

NVCR Last Price Targets
Novocure Ltd

The latest public price target was made on May 3, 2024 by Emily Bodnar from H.C. Wainwright , who expects NVCR stock to rise by 49% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Emily Bodnar
H.C. Wainwright
22 USD
Upside 49%
2 days ago
May 3, 2024
NovoCure Ltd. (NVCR) PT Lowered to $22 at H.C. Wainwright
StreetInsider
Vijay Kumar
Evercore ISI
14.5 USD
Downside 2%
3 days ago
May 2, 2024
NovoCure Ltd. (NVCR) PT Lowered to $14.50 at Evercore ISI
StreetInsider
Jason Bednar
Piper Sandler
28 USD
Upside 89%
3 weeks ago
Apr 10, 2024
NovoCure Ltd. (NVCR) PT Raised to $28 at Piper Sandler
StreetInsider
Larry Biegelsen
Wells Fargo
42 USD
Upside 184%
1 month ago
Apr 3, 2024
NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo
StreetInsider
Unknown Analyst
H.C. Wainwright
24 USD
Upside 62%
1 month ago
Mar 27, 2024
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright following positive METIS data
StreetInsider
Emily Bodnar
H.C. Wainwright
Price Target 22 USD
Upside/Downside 49%
View Source
Vijay Kumar
Evercore ISI
Price Target 14.5 USD
Upside/Downside 2%
View Source
Jason Bednar
Piper Sandler
Price Target 28 USD
Upside/Downside 89%
View Source
Larry Biegelsen
Wells Fargo
Price Target 42 USD
Upside/Downside 184%
View Source
Unknown Analyst
H.C. Wainwright
Price Target 24 USD
Upside/Downside 62%
View Source
Novocure Ltd Competitors:
Price Targets
301363
Mehow Innovative Ltd
46% Upside
DXCM
Dexcom Inc
22% Upside
AXNX
Axonics Inc
9% Upside
REG1V
Revenio Group Oyj
11% Upside
2252
Shanghai MicroPort MedBot Group Co Ltd
94% Upside
STMN
Straumann Holding AG
29% Upside
MLAB
Mesa Laboratories Inc
15% Upside
NPCE
Neuropace Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Novocure Ltd

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 41%. The projected CAGR for the next 3 years is 10%.

41%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVCR's stock price target?
Price Target
27.88 USD

According to Wall Street analysts, the average 1-year price target for NVCR is 27.88 USD with a low forecast of 15.15 USD and a high forecast of 44.1 USD.

What is Novocure Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 41%. The projected CAGR for the next 3 years is 10%.